4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-040058
Director sold 15,000 shares at an average $4.44 ($66,603)
- Director acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Johnston John Joseph Director | 2023-06-26 | Option exercise 10b5-1 | +6,817 | $0.98 | $6,701 | 127,400 | D: show line 1 in the form |
| Johnston John Joseph Director | 2023-06-26 | Option exercise 10b5-1 | +712 | $1.64 | $1,168 | 128,112 | D: show line 2 in the form |
| Johnston John Joseph Director | 2023-06-26 | Sale 10b5-1 | −7,529 | $4.49 | $33,805 | 120,583 | D: show line 3 in the form |
| Johnston John Joseph Director | 2023-06-27 | Option exercise 10b5-1 | +7,471 | $1.64 | $12,260 | 128,054 | D: show line 4 in the form |
| Johnston John Joseph Director | 2023-06-27 | Sale 10b5-1 | −7,471 | $4.39 | $32,798 | 120,583 | D: show line 5 in the form |
| Open-market sales · 15,000 sh · avg $4.44 · $66,603 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Johnston John Joseph Director | 2023-06-26 | Option exercise · Stock Option (right to buy) 10b5-1 | −6,817 | 0 | D: show line 6 in the form | ||
| Johnston John Joseph Director | 2023-06-26 | Option exercise · Stock Option (right to buy) 10b5-1 | −712 | 26,188 | D: show line 7 in the form | ||
| Johnston John Joseph Director | 2023-06-27 | Option exercise · Stock Option (right to buy) 10b5-1 | −7,471 | 18,717 | D: show line 8 in the form |
Loading xslF345X04/doc4.xml…